Puglia HCV Micro-elimination Program (PHCVM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03923595|
Recruitment Status : Unknown
Verified April 2019 by Alessandra Mangia, Casa Sollievo della Sofferenza IRCCS.
Recruitment status was: Recruiting
First Posted : April 22, 2019
Last Update Posted : January 23, 2020
|Condition or disease||Intervention/treatment|
|Hepatitis C||Other: Adherence intervention research|
|Study Type :||Observational|
|Estimated Enrollment :||330 participants|
|Official Title:||The Puglia HCV Micro-elimination in People With Substance Use Disorders|
|Actual Study Start Date :||November 30, 2019|
|Estimated Primary Completion Date :||August 21, 2020|
|Estimated Study Completion Date :||December 21, 2020|
- Other: Adherence intervention research
- Change of linkage to care and treatment of SUD patients with HCV infection [ Time Frame: 15 months ]to link to care a minimum of 80% of those with HCV RNA positive results as in our past experience only 50% of SUD patients positive started treatment in our area.
- Change of discontinuation rates of SUD patients with HCV infection [ Time Frame: 15 months ]To reduce the rate of treatment discontinuation for SUD who start treatment, from 3% to 1.5%
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03923595
|San Giovanni Rotondo, Fg, Italy, 71013|
|Contact: Alessandra Mangia 3393123837 firstname.lastname@example.org|